1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Why You Cannot Afford to Overlook Turkey and Chile for Opportunities in the Global Renal Care Market

Why You Cannot Afford to Overlook Turkey and Chile for Opportunities in the Global Renal Care Market

  • May 2015
  • -
  • Frost & Sullivan
  • -
  • 48 pages

Summary

Table of Contents

Evaluate, Analyze, and Formulate Your Emerging Market Strategy

With the rise in income levels of developing countries, disease profiles are shifting to include the higher prevalence of lifestyle-related diseases such as diabetes, which can have a strong causative correlation with renal disorders. Over the past decade, developing countries have demonstrated significant growth in the prevalence of diabetes and kidney disease. These emerging markets have a strong demand for renal care-related medical devices and services. Given the high prevalence of kidney disease such as chronic and end-stage renal disease, the availability of resources for meeting the demand is still inadequate, indicating a strong presence of untapped opportunities in the global renal care market.

Executive Summary

Business Insight
Several developing countries worldwide have demonstrated strong growth in renal disease cases over the past few years. Growth in causative factors such as diabetes seems to go side-by-side for these countries.

Many of these countries have low imports of renal care devices, even though they have a high prevalence of kidney disease, signaling a lack of ample facilities to meet the demand for renal care.

Growth Insight
The lack of healthcare facilities does not ensure growth potential. Governance effectiveness, in terms of converting healthcare spending to growth in healthcare infrastructure and workforce, indicates potential for growth in healthcare business.

Turkey and Chile are destinations with a high number of patients needing renal care and with strong government support towards boosting the healthcare scenario.

Profit Insight
Both Turkey and Chile have a high demand for renal treatment from domestic patients. In addition, these locations are sought after destinations for medical
tourism for various other forms of treatment.

Given the strong inflow of medical tourists in certain cities, along with the existing number of domestic patients needing renal care, these cities are the most lucrative
locations for investment in renal care.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Polycystic kidney disease (PKD)- Market Insights, Epidemiology and Market Forecast-2023

Polycystic kidney disease (PKD)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Polycystic kidney disease (PKD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

Opportunity in Kidney and Renal Diseases Therapeutics in global market - 2017

Opportunity in Kidney and Renal Diseases Therapeutics in global market - 2017

  • $ 4500
  • Industry report
  • March 2017
  • by Feedback Business Consulting

This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: - Current market size estimate - Revenues by players - Top 5 Companies - Market ...

Global Renal Medical Devices & Services Market - Growth, Trends & Forecast (2017 - 2022)

Global Renal Medical Devices & Services Market - Growth, Trends & Forecast (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The global renal medical devices & services market generated a revenue of about $XX billion in 2015 and is anticipated to grow up to $XX billion at a CAGR of XX% by 2020. Renal disease, a progressive loss ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.